Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 2Glioma 2Colonic Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Ductal Adenocarcinoma 1Pain 1Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Magnetic Resonance Imaging 1Kidney Neoplasms 1Hypothyroidism 1Hyperphagia 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Goiter 1Glioblastoma 1Emergencies 1Critical Illness 1Carcinoma, Renal Cell 1Cancer Pain 1Breast Neoplasms 1

Interventions

Morphine 10Methadone 6Acetaminophen 5Oxycodone 4Lidocaine 4Fentanyl 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Buprenorphine 3Transcranial Direct Current Stimulation 2Surveys and Questionnaires 2Sodium Bicarbonate 2Radiosurgery 2Radiofrequency Ablation 2Pharmaceutical Services 2Ketamine 2Electroacupuncture 2Control Groups 2Analgesics, Opioid 2oxycodone naloxone combination 1nabiximols 1incobotulinumtoxinA 1Water 1Tramadol 1Therapeutic Touch 1Telemedicine 1Tapentadol 1Tablets 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cancer Pain × Glucose × Clear all
NCT01384877 2019-07-12

Subcutaneous Lidocaine For Cancer-Related Pain

British Columbia Cancer Agency

Phase 2/3 Completed
33 enrolled 16 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡